Investors
Overview
Team
Press Releases
SEC Filings
180 Life Sciences
Email Alerts
Contact
SEC Filings
Filing Type:
View All
10-K
10-Q
25-NSE
3
4
424B3
424B4
425
8-K
CERTNAS
CORRESP
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
PRE 14A
S-1
S-4
S-4/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2021
2020
2019
2018
2017
2016
Date
Form
Description
PDF
XBRL
Pages
10/23/20
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Documents
EX-99.1
6
10/19/20
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-5.1
EX-10.24
EX-10.25
EX-23.1
EX-23.2
EX-99.1
EX-99.2
EX-99.3
EX-99.4
EX-99.5
EX-99.6
EX-99.7
352
10/13/20
8-K
Current report filing
Documents
EX-99.1
EX-99.2
40
10/13/20
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Documents
EX-99.1
EX-99.2
40
10/09/20
EFFECT
Notice of Effectiveness
1
10/09/20
424B3
Prospectus filed pursuant to Rule 424(b)(3)
602
10/08/20
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
10/07/20
8-K
Current report filing
Documents
EX-99.1
EX-99.2
12
10/07/20
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Documents
EX-99.1
EX-99.2
12
09/14/20
8-K
Current report filing
Documents
EX-4.1
EX-10.1
EX-10.2
87
Previous
1
2
3
4
5
6
7
8
9
10
…12
Next
Email Alerts
RSS News Feed